跳至主要内容
临床试验/CTRI/2022/07/044168
CTRI/2022/07/044168进行中(未招募)未知

Alactic Base excess, A bedside early prediction tool for sepsis associated Acute kidney injury. A prospective observational study - ABE

IMS and SUM hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Age 18 to 60years
  • 2.ICU patients suspected to be having sepsis as per sepsis-3 definition.7
  • (Increase in SOFA Score by 2 from SOFA score at admission to ICU)

排除标准

  • 1.Patients having ESRD/CKD. ( From Radiological evidence, USG KUB done as per routine ICU protocol in all suspected septic patients in ICU)
  • 2.Patients who are on propofol infusion ( >4mg/kg/hr for > 48hrs) and Metformin ( >3gm per day for at least 6 months)
  • 3.Acute coronary syndrome
  • 4.A known case of Chronic liver disease
  • 5.Patients previously admitted in other ICUs and wards
  • 6.RRT performed for Non renal causes

研究者

发起方
IMS and SUM hospital

相似试验